How Portage Biotech Created A Lean, New Drug Development Model
Source: Life Science Leader
By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical
Dr. Ian Walters was noticing a disturbing trend in the industry. After nearly two decades of working in pharma, seven years of which at Bristol Myers Squibb (BMS), he became aware that Big Pharma companies would often lament that small biotechs did not develop drugs the same way as their larger counterparts. Those differences would often lead many large pharma companies to question whether they should take a risk on a small biotech instead of just doubling down on their own efforts.
VIEW THE MAGAZINE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader X
Subscribe to Life Science Leader